companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

CALEDON MOULD DESIGN

KITCHENER-Canada

Company Name:
Corporate Name:
CALEDON MOULD DESIGN
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 16 Orsi,KITCHENER,ON,Canada 
ZIP Code:
Postal Code:
N2A 
Telephone Number: 5195840516 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
0 
USA SIC Description:
 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
CALLRIGHT MARKETING SVC
CALLRIGHT MARKETING SVC
CALLONE TELECOMMUNICATI
Next company profile:
CALDWELL CAPITAL CORP
CALCULATED SUCCESS INC
CAKEBOX










Company News:
  • Home | Otsuka US
    Otsuka is a healthcare company driven by our purpose and defined by our beliefs
  • Otsuka Holdings Co. , Ltd.
    Based on the corporate philosophy of ‘Otsuka - people creating new products for better health worldwide’, Otsuka Holdings aims to lead a global value-creating group that is dedicated to contributing to a more healthy and prosperous life for people the world over
  • Otsuka Pharmaceutical - Wikipedia
    Otsuka Pharmaceutical Co , Ltd (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan
  • Otsuka Pharmaceutical Co. , Ltd.
    Otsuka Pharmaceutical is a holistic healthcare company contributing to people's health worldwide through two core businesses: pharmaceuticals and nutraceuticals
  • Otsuka America
    For over 100 years, Otsuka has been committed to creating innovative treatments that enhance and promote better health and overall well-being Through the spirit of “Jissho” (actualization) and “Sozosei” (creativity), Otsuka has created a global presence in the pharmaceutical, nutraceutical, and consumer realms
  • Otsuka to acquire Cantargia’s CAN10 for autoimmune diseases
    Otsuka Pharmaceutical has signed an agreement to acquire all assets related to Cantargia's early-clinical stage CAN10 programme
  • About Otsuka | Corporate Information | Otsuka Medical Devices Co. , Ltd.
    Aiming to address health issues, the Otsuka group operates a diverse range of businesses, mainly in the pharmaceutical and nutraceutical (NC) businesses, across more than 30 countries and regions around the world We create new value and strive to contribute to people's well-being worldwide
  • Products | Otsuka US
    Our product specialties include neuroscience, digital innovation, nephrology, oncology, and medical devices Discover additional resources for patients and caregivers List of products that have been developed, acquired, or in-licensed by Otsuka
  • About Our Group | Otsuka Holdings Co. , Ltd.
    In keeping with our corporate philosophy, “Otsuka-people creating new products for better health worldwide,” and the Otsuka values of Ryukan-godo (by sweat we recognize the way), Jissho (actualization), and Sozosei (creativity), we strive every day to do what only Otsuka can do
  • Cantargia announces the acquisition of its CAN10 IL1RAP immunology . . .
    Cantargia receives an upfront cash payment of USD 33 million Cantargia is eligible to receive up to USD 580 million in development, regulatory and commercial milestone payments plus earn-out payments from global product sales Otsuka Pharmaceutical obtains worldwide rights for the development and commercialization of the CAN10 program




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer